FCCM
ATOS icon

First City Capital Management’s Atossa Therapeutics ATOS Stock Holding History

First City Capital Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7
Closed -$20.3K – 638
2015
Q2 		$20.3K Hold
7
– – 0.01% 372
2015
Q1 		$32.4K Buy
+7
New +$29.9K 0.02% 311

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CWM
Concert Wealth Management San Jose, California $24.7M AUM 14.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

First City Capital Management's ATOS Position: Q3 2015 in Review

First City Capital Management sold out of Atossa Therapeutics (ATOS) in Q3 2015, closing a stake of 7 shares — an estimated $20.3K sold.

First City Capital Management first reported a position in ATOS in Q1 2015 and held it in 2 quarters. The position peaked at $32.4K in Q1 2015. 12 funds tracked by Wall St. Rank hold ATOS as of Q3 2015.

  • First City Capital Management reported no remaining Atossa Therapeutics position as of Q3 2015 after selling out during the quarter.
  • First City Capital Management sold 7 Atossa Therapeutics shares in Q3 2015, an estimated $20.3K.
  • First City Capital Management first reported a position in Atossa Therapeutics in Q1 2015 and held it in 2 quarters.
  • First City Capital Management's Atossa Therapeutics position peaked at $32.4K in Q1 2015.
  • 12 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2015.

Based on First City Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.